Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Status:
Completed
Trial end date:
1996-09-01
Target enrollment:
Participant gender:
Summary
A study to compare rizatriptan 10 mg verse sumatriptan 100 mg in the treatment of migraine
attacks and duration of relief provided. This study will also provide additional efficacy
data on rizatriptan 5 mg and 10 mg for the treatment of migraine.